Overview

Usefulness of Non TNF Usage in RA Patients

Status:
Recruiting

Trial end date:
2024-12-16

Target enrollment:

Participant gender:

Summary

The aim of this study is to examine the efficacy and adverse events in the following 3 groups in rheumatoid arthritis patients: 1. Sarilumab treatment for 12 months 2. Tocilizmab treatment for 12 months 3. Abatacept treatment for 12 months

Phase:

Phase 2

Details

Lead Sponsor:

Shinshu University

Treatments:

Abatacept